medigraphic.com
SPANISH

Medimay

ISSN 2520-9078 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 1

<< Back Next >>

Revista de Ciencias Médicas de la Habana 2014; 20 (1)

Characterization of renal cancer, relation of tumor size and nuclear grade with survival

Norman PA, Chong LA, Pernas GA
Full text How to cite this article

Language: Spanish
References: 14
Page: 34-43
PDF size: 193.34 Kb.


Key words:

renal cancer, survival, tumor size, Fuhrman nuclear grade.

ABSTRACT

Introduction: renal cancer accounts for 3 % of adult malignant neoplasies.
Objective: to assess new clinical and histological features associated with the new classifications, to characterize in a clinical-pathological way, patients treated for renal cancer, according to updated criteria, to describe some variables of interest, and to estimate the overall five-year survival evolution of the different histological subtypes more frequent and its relation to the size and nuclear grade.
Method: an ambispective, descriptive research was conducted in the Department of Pathological Anatomy of "Hermanos Ameijeiras" Hospital with 112 patients treated for malignant renal tumors during the period between 2004 and 2006. The variables used were: variables: survival time, patient state, nuclear grade, and tumor size.
Results: the most frequently diagnosed histological type was clear cell carcinoma, with a total of 76 cases. The highest percentage of cases had average size between 4 and 7 cm in diameter. It was seen that most of the cases were classified into the Fuhrman nuclear grade 2.
Conclusions: clear cell carcinoma remains the worst prognosis of survival. The tumor size and nuclear grade showed significant differences regarding the survival of patients, to match the worst behavior to those of larger size or nuclear grade.


REFERENCES

  1. Sánchez-Martín FM, Millán-Rodríguez F, Urdaneta-Pignalosa G, Rubio- Briones J, Villavicencio-Mavrich H. Small renal masses: incidental diagnosis, clinical symptoms, and prognostic factors. Adv Urol [Internet]. 2008 [citado 20 Mar 2013];310. Disponible en: http://www.hindawi.com/journals/au/2008/310694/

  2. Bassil B, Dosoretz DE, Prout GR. Validation of tumor, nodes, metastasis classification of renal cell carcinoma. Journal of Urology [Internet]. 1985 [citado 20 Mar 2013]134(3). Disponible en: http://www.researchgate.net/publicliterature.PublicPublicationPromoRequestF ulltext.signup.html?publicationUid=19128483&ev=su_pub_req

  3. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics. CA Cancer J Clin [Internet]. 2007 [citado 20 Mar 2013];61(4). Disponible en: http://onlinelibrary.wiley.com/doi/10.3322/caac.20121/full

  4. Wong-Ho C, Devesa SS, Warren JL, Fraumeni JF. Rising incidence of renal cell cancer in the United States. JAMA [Internet]. 1999 [citado 20 Mar 2013];281. Disponible en: http://jama.jamanetwork.com/article.aspx?articleid=189733

  5. Svatek RS, Lotan Y, Hermann M. The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma. J Urol [Internet]. Oct 2005 [citado 20 Mar 2013];176(4). Disponible en: http://www.jurology.com/article/S0022-5347(06)01380-2/fulltext

  6. Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol [Internet]. 2005 [citado 20 Mar 2013];173(6). Disponible en: http://www.jurology.com/article/S0022-5347(05)60160- 7/abstract

  7. Bostwick DG, Eble JN. Diagnosis and classification of renal cell carcinoma. Urol Clin North Am 1999;26:627.

  8. López-Beltrán A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol [Internet]. 2006 [citado 20 Mar 2013];49(5). Disponible en: http://www.researchgate.net/profile/Antonio_Lopezhttp Beltran/publication/7331867_2004_WHO_classification_of_the_renal_tumors_ of_the_adults/file/d912f5072b5e4d1a1c.pdf

  9. Giménez Bachs JM, Donate Moreno MJ, Salinas Sánchez AS. Incidencia creciente en el carcinoma de células renales. Actas Urol Esp [Internet]. 2006 [citado 20 Mar 2013];30(3). Disponible en: http://scielo.isciii.es/scielo.php?pid=S021048062006000300007&script=sci_art text

  10. Budía Alba A, Gómez Pérez L, Bango V, Ruiz-Cerdá JI, Sempere A, Queipo JA, et al. Prognostic factors for disease progression in patients with renal cell carcinoma. Actas Urol Esp [Internet]. 2007 [citado 20 Mar 2013];31(8). Disponible en: http://www.uptodate.com/contents/prognostic-factors-inpatients- with-renal-cell-carcinoma

  11. Arroyo-López R, Aragón-Tovar R, López-Verdugo JF, Castillo-Chavira G, Zavala-Pompa A, Vargas-Valtierra P. Correlación de los hallazgos histopatológicos, tamaño, grado y estadio con la multifocalidad en el cáncer de riñón. Rev Mex Urol [Internet]. 2009 [citado 20 Mar 2013];69(6). Disponible en: http://www.medigraphic.com/pdfs/uro/ur-2009/ur096e.pdf

  12. Sánchez Salabardo DJ, López Ferrandis J, Arocena García-Tapia J, Rogojo Balboa JM, Fernández Montero D. Rosell Costa JE, et al. Clínica, diagnóstico y pronóstico del carcinoma renal. Actas Urol Esp [Internet]. 2002 [citado 20 Mar 2013];26(8). Disponible en: http://apps.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=13144526 &pident_usuario=0&pcontactid=&pident_revista=292&ty=98&accion=L&origen =zonadelectura&web=zl.elsevier.es&lan=es&fichero=292v26n08a13144526pd f001.pdf

  13. Fernández Pineda I, Cabello Laureano R, Maraví Petri A, Carranza Carranza A, Congregado Córdoba J, De Agustín Asensio JC. Carcinoma renal de células cromófobas, una entidad excepcional en la infancia: caso clínico. Actas Urol Esp [Internet]. 2008 [citado 20 Mar 2013];32(6). Disponible en: http://scielo.isciii.es/pdf/aue/v32n6/v32n6a17.pdf

  14. Algaba F, Arce Y, Trias I, Santaularia JM, Antonio Rosales A. Aplicación clínica de las actuales clasificaciones del cáncer renal. Actas Urol Esp [Internet]. 2006 [citado 20 Mar 2013];30(4). Disponible en: http://scielo.isciii.es/scielo.php?pid=S021048062006000400005&script=sci_art text




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Revista de Ciencias Médicas de la Habana. 2014;20